WEKO3
アイテム
Tc-99m MAG3 Renogram is a Useful Non-Invasive Diagnostic Tool to Evaluate Renal Function After Carbon-Ion Radiotherapy (CIRT) in Patients with Renal Cell Carcinoma
https://repo.qst.go.jp/records/77929
https://repo.qst.go.jp/records/7792948f5345e-9775-4f43-8f0e-fb2105795d35
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2019-12-11 | |||||
タイトル | ||||||
タイトル | Tc-99m MAG3 Renogram is a Useful Non-Invasive Diagnostic Tool to Evaluate Renal Function After Carbon-Ion Radiotherapy (CIRT) in Patients with Renal Cell Carcinoma | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Nishii, Ryuichi
× Nishii, Ryuichi× Yamazaki, Kana× Kasuya, Goro× Makishima, Hirokazu× Chang, Tachen× Tsuji, Hiroshi× Higashi, Tatsuya× Nishii, Ryuichi× Yamazaki, Kana× Kasuya, Goro× Makishima, Hirokazu× Chang, Tachen× Tsuji, Hiroshi× Higashi, Tatsuya |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | TEACHING POINTS 1) 99mTc-MAG3 renogram is a useful non-invasive diagnostic tool to evaluate renal function after CIRT in patients with renal cell carcinoma, especially for the assessment of split renal function. 2) With 99mTc-MAG3 renogram, it is possible to detect renal function deterioration of non-irradiated renal parenchyma. 3) Serial assessment of renal function by measuring tubular extraction with 99mTc-MAG3 might permit earlier and more sensitive detection of renal damage after CIRT. TABLE OF CONTENTS/OUTLINE # Background # Contents - Renogram before and after CIRT for RCC. - Renogram; Pre-, 3-6 months and 12-18 months after CIRT with comparison National Cancer Institute's Common Terminology Criteria for Adverse Events (CTCAE) version 4.0 as adverse event evaluation. - Relationship between total cERPF and eGFR # Case presentation, - Case: T1aN0M0, 66Gy/12Fr., Comorbidity: none - Case: T1bN0M0, 66Gy/12Fr., Comorbidity: none - Case: T1bN0M0, 66Gy/12Fr., Cerebrovascular disease - Case: T1aN0M0, 72Gy/12Fr., Cerebrovascular disease - Case: T1aN0M0, 72Gy/12Fr., Diabetic nephropathy - Case: T3aN0M0, 72Gy/12Fr., Diabetic nephropathy # Summary |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | RSNA2019 | |||||
発表年月日 | ||||||
日付 | 2019-12-05 | |||||
日付タイプ | Issued |